News Trends, News Analysis, News Archive.



Related Articles

healthNews reuters.com

NZ's Fisher & Paykel sues Resmed in Australia over patent dispute

(Reuters) - New Zealand's Fisher & Paykel Healthcare filed a lawsuit in Australia on Tuesday against Resmed Inc alleging the medical device manufacturer's respiratory treatment products violate four Fisher & Paykel patents.

healthNews reuters.com

Air pollution fine particles linked to poor sperm quality

(Reuters Health) - Exposure to fine particles in air pollution may be another factor that affects men’s sperm quality and their fertility, suggest researchers in Taiwan.

healthNews reuters.com

Retirement linked to longer, better sleep

(Reuters Health) – As work worries abate, sleep difficulties may also diminish when workers make the transition to retirement, according to a recent study from Finland.

healthNews reuters.com

Amgen's Kyprolis improves overall survival in blood cancer patients

(Reuters) - Amgen Inc said on Monday new data from a late-stage trial testing Kyprolis in combination with two other drugs showed improved overall survival rate in patients with blood cancer.

healthNews reuters.com

Promising responses seen with Agios leukemia drug in study

(Reuters) - Nearly a third of patients with an advanced form of a fast-progressing leukemia who carry a specific genetic mutation experienced a complete or near complete response to an experimental Agios Pharmaceuticals drug, according to data from an early stage trial released on Monday.

healthNews reuters.com

Breast reconstruction after cancer less common at cash-strapped hospitals

(Reuters Health) - Women with breast cancer who have one or both breasts removed are less likely to get immediate reconstruction surgery at hospitals that are struggling financially, a U.S. study suggests.

healthNews reuters.com

Commuters often exposed to damaging noise levels

(Reuters Health) - Loud noise exceeding levels that can damage hearing is regularly encountered by commuters using buses, subways and even biking, a Canadian study suggests.

healthNews reuters.com

Kids continue to die in window-blind accidents, despite safety warnings

(Reuters Health) - Even though window coverings have been recognized for decades as a safety hazard to children, injuries from blinds and shades still send many kids to the emergency room each year, a U.S. study suggests.

healthNews reuters.com

FDA OKs Sanofi's follow-on biologic of Lilly's diabetes drug Humalog

(Reuters) - The U.S. Food and Drug Administration said on Monday it approved Sanofi SA's Admelog as the first follow-on biologic version of Eli Lilly and Co's fast-acting insulin, Humalog.

healthNews reuters.com

Austria to drop impending smoking ban, bucking Western trend

VIENNA (Reuters) - While much of the West has barred smoking in restaurants and bars, Austria's impending ban is set to be stubbed out.

healthNews reuters.com

Opioid painkiller prescriptions may run in families

Reuters Health - When one person in a household gets prescribed opioids, the other people who live with them are more likely to get their own prescriptions for these narcotic painkillers, a U.S. study suggests.

healthNews reuters.com

'Ground-breaking' new drug gives hope in Huntington's disease

LONDON (Reuters) - Scientists have for the first time fixed a protein defect that causes Huntington's disease by injecting a drug from Ionis Pharmaceuticals into the spine, offering new hope for patients with the devastating genetic disease.

healthNews reuters.com

'Ground-breaking' new drug gives hope on Huntingdon's disease

LONDON (Reuters) - Scientists have for the first time fixed a protein defect that causes Huntingdon's disease by injecting a drug from Ionis Pharmaceuticals into the spine, offering new hope for patients with the devastating genetic disease.

healthNews reuters.com

Indonesia races to contain diphtheria outbreak ahead of 2018 Asian Games

JAKARTA (Reuters) - Health authorities in Jakarta kicked off a special immunization program on Monday to rein in an "extraordinary" outbreak of diphtheria that has sparked concerns about the Indonesian capital’s readiness to host the Asian Games next June. Diphtheria cases have spiked 42 percent since last year, health officials say, with at least 32 deaths and more than 590 cases recorded across the archipelago, the bulk of them in densely populated Jakarta and neighboring provinces.

healthNews reuters.com

GSK's new pharma head on lookout for cancer deals to boost pipeline

LONDON (Reuters) - GlaxoSmithKline will scout for deal opportunities in cancer medicine, as well as immunology, as the drugmaker seeks to rebuild its presence in oncology, its new head of pharmaceuticals told Reuters.

healthNews reuters.com

Roche: Tecentriq cocktail slows kidney cancer progression

ZURICH (Reuters) - Combining Roche's Tecentriq immunotherapy with its older drug Avastin reduced the risk of disease worsening or death (PFS) for the initial treatment of advanced kidney cancer in some patients, the Swiss drugmaker said on Monday

companyNews reuters.com

UPDATE 1-Roche: Tecentriq cocktail slows kidney cancer progression

ZURICH, Dec 11 (Reuters) - Combining Roche's Tecentriq immunotherapy with its older drug Avastin reduced the risk of disease worsening or death (PFS) for the initial treatment of advanced kidney cancer in some patients, the Swiss drugmaker said on Monday

healthNews reuters.com

Merck raises stakes in lung cancer as rivals close in

LOS ANGELES (Reuters) - Merck & Co Inc, maker of the only immunotherapy approved for patients newly-diagnosed with the most common type of lung cancer, could solidify its lead by playing the long game, even as rivals edge closer.

healthNews reuters.com

Hospital operators in merger talks to form U.S. industry leader: WSJ

NEW YORK (Reuters) - Ascension Health and Providence St. Joseph Health are in talks about a merger between the two Catholic non-profits that would create the largest U.S. hospital chain, the Wall Street Journal reported on Sunday, citing people familiar with the discussions.

healthNews reuters.com

Hospital operators in merger talks to create U.S. industry leader: WSJ

NEW YORK (Reuters) - Ascension Health and Providence St. Joseph Health are in discussions about a merger that would create the largest hospital chain in the United States, the Wall Street Journal reported on Sunday, citing people familiar with the situation.

healthNews reuters.com

Exclusive: Philippines defied experts' advice in pursuing dengue immunization program

MANILA (Reuters) - As she announced in January 2016 that the Philippines would immunize one million children with a new dengue vaccine, the nation's then health secretary Janette Garin boasted it was a world-first and a tribute to her country's "expertise" in research.

healthNews reuters.com

France orders international recall of Lactalis baby formula

PARIS (Reuters) - France has ordered banned the sale and ordered a recall of several baby formula milk and baby food products made by French dairy giant Lactalis after the discovery of salmonella bacteria, consumer protection agency DGCCRF said in a statement.

healthNews reuters.com

Gilead's new drug keeps 56 percent of lymphoma trial patients alive

(Reuters) - More than half of trial patients with an advanced, aggressive form of blood cancer lived for at least a year after one-time treatment with Yescarta, a novel therapy sold by Gilead Sciences Inc, according to study results presented on Sunday.

healthNews reuters.com

Roche lymphoma drug drives high remission rate, longer survival: study

(Reuters) - An experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced, aggressive blood cancer live significantly longer than the standard treatment alone, according to data from a mid-stage trial released at a medical meeting on Sunday.

companyNews reuters.com

Roche lymphoma drug drives high remission rate, longer survival-study

Dec 10 (Reuters) - An experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced, aggressive blood cancer live significantly longer than the standard treatment alone, according to data from a mid-stage trial released at a medical meeting on Sunday.

Cancer nytimes.com

Caring for a Son With Cancer, and for Herself

Andrew gave his mother, Regina Hensley, a reason to live. We follow the pair as she fights a history of addiction and he fights an aggressive form of cancer.

worldNews reuters.com

Japan arrests North Korean crew amid mystery boat arrivals

TOKYO (Reuters) - Japanese police arrested three crew of a North Korean boat on Saturday for stealing a generator from a hut on an uninhabited island, public broadcaster NHK said, the latest drama amid increasing arrivals of North Korean fishing boats off Japan.

healthNews reuters.com

U.S. House committee 'may reconsider' WHO cancer agency funds

LONDON (Reuters) - U.S. congressional committee members warned on Friday that Washington's funding of the World Health Organization's cancer research agency could be halted unless it is more open about its operations.

healthNews reuters.com

Lilly's stomach cancer drug meets main goal, but fails to improve survival rate

(Reuters) - Eli Lilly & Co said on Friday a late-stage trial testing its drug, Cyramza, as a gastric cancer treatment met the main goal of preventing the disease from advancing, but failed its secondary target of improving overall survival rates.

companyNews reuters.com

UPDATE 1-Lilly's stomach cancer drug meets main goal, but fails to improve survival rate

Dec 8 (Reuters) - Eli Lilly & Co said on Friday a late-stage trial testing its drug, Cyramza, as a gastric cancer treatment met the main goal of preventing the disease from advancing, but failed its secondary target of improving overall survival rates.

companyNews reuters.com

REFILE-Lilly's Cyramza meets main goal in gastric cancer study

Dec 8 (Reuters) - Eli Lilly & Co said on Friday a late-stage trial testing its drug, Cyramza, as a treatment for a type of gastric cancer met its main goal of preventing the disease from advancing.

companyNews reuters.com

BRIEF-Lilly's Cyramza meets Primary Endpoint in gastric cancer study

* LILLY REPORTS TOP-LINE RESULTS FROM CYRAMZA® (RAMUCIRUMAB) PHASE 3 STUDY IN FIRST-LINE ADVANCED GASTRIC CANCER

healthNews reuters.com

Lilly's Cyramza meets main goal in gastric cancer study

(Reuters) - Eli Lilly & Co said on Friday a late-stage trial testing its drug, Cyramza, as a treatment for a type of gastric cancer met its main goal of preventing the disease from advancing.

healthNews reuters.com

Depression in late teens linked to high school drop out

(Reuters Health) - Older teens struggling with depression are more than twice as likely to drop out of high school as peers without that mental illness or those who recovered from a bout of depression earlier in life, Canadian researchers say.

healthNews reuters.com

Kids who get moving may also get better grades

(Reuters Health) - Students who get extra physical activity may pay more attention in school and do better in subjects like reading and math, a research review suggests.

healthNews reuters.com

Acupressure app may help ease menstrual cramp pain

(Reuters Health) - Women with intense menstrual cramp pain may get more relief from smartphone app-guided acupressure than with typical medical treatments like painkillers, a recent study suggests.

healthNews reuters.com

Credibility, recipes, references help food blogs improve eating habits

(Reuters Health) - Consumers like healthy eating blogs written by nutritionists who seem credible and who interact with their readers, a small study in Canada suggests.

healthNews reuters.com

Uganda says it has contained an outbreak of Marburg hemorrhagic fever

KAMPALA (Reuters) - Uganda said on Friday it had successfully contained an outbreak of the Marburg virus, a highly infectious haemorrhagic fever announced by officials on Oct. 19, which killed three people.

healthNews reuters.com

Pfizer breast cancer drug superior to chemotherapy in late stage study

(Reuters) - Patients with advanced breast cancer tied to an inherited gene mutation who were treated with an experimental Pfizer Inc drug went about three months longer before their disease worsened than those who received chemotherapy in a late stage study, according to data released on Friday.

companyNews reuters.com

EU's Vestager to meet Google's unhappy shopping rivals

BRUSSELS, Dec 8 (Reuters) - Europe's antitrust chief Margrethe Vestager will meet with foes of Alphabet unit Google amid mounting criticism that the company's proposal to treat competitors equally was not working out.

companyNews reuters.com

Pfizer breast cancer drug superior to chemotherapy in Phase III study

Dec 8 (Reuters) - Patients with advanced breast cancer tied to an inherited gene mutation who were treated with an experimental Pfizer Inc drug went about three months longer before their disease worsened than those who received chemotherapy in a late stage study, according to data released on Friday.

healthNews reuters.com

Top Russian pork producer Miratorg reports ASF outbreak

MOSCOW (Reuters) - Russia's largest pork producer Miratorg on Friday reported an outbreak of African Swine Fever (ASF) at one of its sites in the Belgorod region in central Russia.

businessNews reuters.com

Roche, Novartis' Italian heads risk trial for alleged market rigging: sources

ROME (Reuters) - The local heads of Swiss drugmakers Roche and Novartis risk facing trial in Italy for alleged market manipulation, judicial sources said on Friday.

healthNews reuters.com

Venezuela's chronic shortages give rise to 'medical flea markets'

SAN CRISTOBAL/MARACAIBO, Venezuela (Reuters) - Venezuela's critical medicine shortage has spurred "medical flea markets," where peddlers offer everything from antibiotics to contraceptives laid out among the traditional fruits and vegetables.

healthNews reuters.com

Russia's meat firm Miratorg reports ASF outbreak at 1 site in Russia

MOSCOW (Reuters) - Russian privately-owned meat producer Miratorg said on Friday there was an outbreak of African Swine Fever (ASF) at one of its sites in Russia's Belgorod region.

healthNews reuters.com

Philippines to seek refund of $59 million from Sanofi amid vaccine risk

MANILA (Reuters) - The Philippines will seek the return of 3 billion pesos ($59 million) it paid French drugmaker Sanofi for a dengue vaccine used to immunize hundreds of thousands of children that Sanofi has said could worsen the disease in some cases.

cnn.com

Bitcoin plunges $2,500 in less than four hours

healthNews reuters.com

Roche study finds cancer 'Velcro' that halts T-cell attack

ZURICH (Reuters) - Scientists at Swiss drugmaker Roche said on Friday they may have discovered why some tumors resist new immunotherapy drugs as well as a possible means of turning the tables to incite a T-cell attack.

healthNews reuters.com

U.S. Department of Justice investigating fetal tissue transfers

(Reuters) - The U.S. Department of Justice asked on Thursday for documents related to a Senate committee's report on the transfer of fetal tissue by abortion provider Planned Parenthood, according to a letter seen by Reuters.

healthNews reuters.com

U.S. Department of Justice seeks documents on fetal tissue transfers

(Reuters) - The U.S. Department of Justice sent a letter on Thursday, seen by Reuters, seeking documents related to a Senate committee's report on the transfer of fetal tissue by abortion provider Planned Parenthood.

healthNews reuters.com

Antibiotics sales for use in U.S. farm animals dropped in 2016: FDA

CHICAGO (Reuters) - The sale and distribution of antibiotics approved for use in food-producing animals in the United States decreased by 10 percent from 2015 to 2016, a U.S. Food and Drug Administration (FDA) report said on Thursday.

healthNews reuters.com

Childhood cancer survivors have more blood pressure problems

(Reuters Health) - More than one in 12 adult survivors of childhood cancers may have undiagnosed high blood pressure, a U.S. study suggests.

healthNews reuters.com

Faulty positioning in rugby tackles boosts injury risk

(Reuters Health) - Head, neck and shoulder injuries during rugby tackles are more common when the tackler’s head is incorrectly positioned in relation to the ball carrier, a small study has found.

healthNews reuters.com

Gum infections tied to increased risk of stomach cancer precursor

(Reuters Health) - Gum infections may increase people’s risk for sores in the digestive tract that can lead to stomach cancer, a small study suggests.

healthNews reuters.com

Open windows and doors can improve sleep quality

(Reuters Health) - Leaving a bedroom door or window open may help people sleep better, a study from the Netherlands suggests.

healthNews reuters.com

Sage shares surge as depression drug succeeds in mid-stage trial

(Reuters) - Drug developer Sage Therapeutics Inc's shares soared as much as 85 percent to a record high on Thursday after its experimental drug to reduce the symptoms of depression succeeded in a mid-stage trial.

companyNews reuters.com

UPDATE 5-Roche drug cocktail doubles chance of holding lung cancer at bay

* Analysts see drug sales topping $4.6 bln by 2023 - poll (Adds analyst comment)

Florence (Italy) nytimes.com

Florence Journal: ‘Taxi Therapy’ for Young Cancer Patients in Italy

In Florence, Caterina Bellandi, or Zia Caterina, gives free rides and adds a colorful note to the lives of children battling cancer.

healthNews reuters.com

South African egg prices seen rising 20 percent after avian flu outbreak

JOHANNESBURG (Reuters) - Egg prices in South Africa are expected to increase by as much as 20 percent after an outbreak of the highly pathogenic avian flu in June forced farmers to cull egg laying birds, industry experts said on Thursday.

healthNews reuters.com

More than 2,000 drugs now in cancer immunotherapy race

LONDON (Reuters) - The race to develop new immunotherapy treatments against cancer has sparked an unprecedented explosion in the oncology drug pipeline, with more than 2,000 immune system-boosting agents now in development.

cnn.com

Hormonal birth control increases breast cancer risk

Birth control can increase a woman's risk of breast cancer by up to 38%, depending on how long she has taken it, a new study finds.

healthNews reuters.com

Sage shares surge as depression drug succeeds mid-stage trial

(Reuters) - Sage Therapeutics Inc's shares surged more than 63 percent premarket on Thursday, on track to add about $2.5 billion to the company's market value, after its drug succeeded in reducing the symptoms of depression in a mid-stage trial.

healthNews reuters.com

Sage's depression drug succeeds in mid-stage study, shares soar

(Reuters) - Sage Therapeutics Inc said on Thursday its drug to treat patients with moderate to severe depression met the main goal of reducing symptoms in a mid-stage study, sending its shares soaring 52.3 percent in premarket trading.

healthNews reuters.com

Indonesia fights 'extraordinary' diphtheria outbreak that has killed 32

JAKARTA (Reuters) - Indonesian health authorities will launch an immunization drive next week to contain a sharp rise in cases of diphtheria, which has killed at least 32 people, including many children, in the world's fourth most populous country this year.

companyNews reuters.com

UPDATE 3-Roche drug cocktail doubles chance of holding lung cancer at bay

* Tecentriq drug cocktail cuts risk of disease progressing by 38 pct

companyNews reuters.com

UPDATE 2-Roche drug cocktail doubles chance of holding lung cancer at bay

* Tecentriq drug cocktail cuts risk of disease progressing by 38 pct

companyNews reuters.com

UPDATE 1-Roche drug cocktail doubles chance of holding lung cancer at bay

ZURICH, Dec 7 (Reuters) - Adding Roche's immunotherapy Tecentriq to older drugs doubled the percentage of lung cancer patients who survived a year without their disease advancing, an outcome some experts labeled unprecedented.

businessNews reuters.com

HSBC has 3-year head start on foreign investment banking rivals in China: Gulliver

HONG KONG (Reuters) - HSBC has a three-year head start on its foreign investment banking rivals in China because of the British bank's unique position of having management control of its securities venture there, chief executive Stuart Gulliver said on Thursday.

companyNews reuters.com

Roche drug cocktail doubles chance of holding lung cancer at bay

ZURICH, Dec 7 (Reuters) - Adding Roche's immunotherapy Tecentriq to older drugs doubled the percentage of lung cancer patients who survived a year without their disease advancing, an outcome some experts labeled unprecedented.

healthNews reuters.com

Knee surgery outcomes linked with education level

(Reuters Health) - Patients who live in low-income communities and lack a college education may have worse pain after knee replacement surgery than their more educated neighbors, a recent study suggests.

Hormones nytimes.com

Birth Control Pills Still Linked to Breast Cancer, Study Finds

Women using birth control pills and I.U.D.s that release hormones face a higher risk than those using methods without hormones, scientists in Denmark reported.

healthNews reuters.com

Study confirms higher breast cancer risk with hormone-based contraception

(Reuters Health) - Women who currently use or recently used hormone-based contraception face a 20 percent higher risk of breast cancer, although the overall risk for most women is relatively low, a new study of 1.8 million women in Denmark has concluded.

healthNews reuters.com

U.S. healthcare spending growth slowed in 2016

(Reuters) - Growth in healthcare spending in the United States slowed in 2016 following two years of expansion under the Affordable Care Act, a government health agency reported on Wednesday.

healthNews reuters.com

Home births in rural areas just as safe as in cities

(Reuters Health) - Home births may not be more dangerous for healthy rural mothers than for their urban counterparts, a recent U.S. study suggests.

businessNews reuters.com

Canada's swipe at Boeing jets could open way for European rivals

OTTAWA (Reuters) - Canada's decision to shun Boeing Co jets could open the way for European rivals seeking to supply new fighters, assuming the government can sort out major procurement challenges, three sources familiar with the matter said on Wednesday.

healthNews reuters.com

Roche to seize leap-frog opportunity in lung cancer

LONDON (Reuters) - After lagging rivals in cancer immunotherapies, Swiss drugmaker Roche hopes to leap-frog into the lead in the biggest market, tackling previously untreated lung cancer.

companyNews reuters.com

UPDATE 1-Roche to seize leap-frog opportunity in lung cancer

* Roche CEO sees shake-out in crowded cancer R&D field (Adds sales forecasts, further details)

healthNews reuters.com

Kids aren’t protecting themselves against STDs during oral sex

(Reuters Health) - Adolescents and young adults regularly engage in oral sex but seldom use condoms to prevent the spread of sexually transmitted diseases, new research shows.

healthNews reuters.com

FDA proposes drug development guidance for rare pediatric diseases

(Reuters) - The U.S. Food and Drug Administration issued a draft guidance on Wednesday to simplify the procedure of developing drugs for rare pediatric disorders, such as Gaucher's disease, by eliminating the need for certain trials and minimizing patient enrollment.

healthNews reuters.com

Sign-ups pick up in week five of 2018 Obamacare open enrollment - U.S.

WASHINGTON (Reuters) - The number of people signing up for 2018 Obamacare plans picked up significantly during the fifth week of open enrollment, a U.S. government agency reported on Wednesday, but the number of people signed up for such plans appears to be falling short of last year's numbers with just over a week of enrollment left.

healthNews reuters.com

Myanmar's opium crop plummets, but no victory over Asia's narco-boom: U.N.

BANGKOK (Reuters) - A "dramatic" drop in opium cultivation in Myanmar underscored a regional boom in demand for illegal synthetic drugs such as methamphetamine, which many Asian countries are struggling to combat, a senior U.N. official said on Wednesday.

entertainmentNews reuters.com

Johnny Hallyday, 'French Elvis', dies at 74 after cancer

PARIS (Reuters) - Johnny Hallyday, whose death at 74 was announced by his wife and the French president on Wednesday, was a rock and roll giant in his native France and survived drug use, family strife and near-death episodes to strut the stage for more than fifty years.

entertainmentNews reuters.com

French rocker Johnny Hallyday dies at 74 after battle with cancer

PARIS (Reuters) - Johnny Hallyday, a singer known as the "French Elvis" whose cowboy swagger and gravelly voice helped popularize rock 'n roll in his country, has died at 74 after a battle with cancer, the office of the French president said on Wednesday.

entertainmentNews reuters.com

French singer Johnny Hallyday dies at 74 after battle with cancer

PARIS (Reuters) - Johnny Hallyday, a singer known as the "French Elvis" who helped popularize rock 'n roll in his country, has died at 74 after a battle with cancer, the office of the French president said on Wednesday.

healthNews reuters.com

GSK, other drugmakers bet on post-Brexit UK science

LONDON (Reuters) - Britain won a vote of confidence from its economically important life sciences sector on Wednesday as five drug companies committed to invest in the country under the government's industrial strategy plans after Brexit.

healthNews reuters.com

Australian watchdog takes GlaxoSmithKline, Novartis units to court

(Reuters) - The Australian Competition and Consumer Commission (ACCC) on Wednesday said it is taking local units of GlaxoSmithKline and Swiss healthcare company Novartis to court over false or misleading representations in the marketing of pain relief products.

healthNews reuters.com

Consistently lower cancer survival rates for black patients in U.S.

(Reuters Health) - Whether it's colon cancer, breast cancer, or ovarian cancer, survival rates in the U.S. are lower for black people than for white people, three new studies show.

healthNews reuters.com

Brazil, U.S. identify molecule to help fight citrus greening disease

SAO PAULO (Reuters) - Researchers have identified the molecule that attracts the insect that transmits citrus greening disease, a development expected to help farmers control a plague that has destroyed trees in growing regions of Brazil and the United States.

healthNews reuters.com

Paraguay Congress legalizes planting of medical marijuana

ASUNCION (Reuters) - Paraguay's Congress passed a bill on Tuesday creating a state-sponsored system to import marijuana seeds and grow the plant for medical uses, a decision that followed other countries in Latin America.

healthNews reuters.com

Eating almonds with chocolate may lower cholesterol

(Reuters Health) - Overweight and obese people who eat almonds and chocolate every day may have lower cholesterol than their counterparts who don’t consume these foods, a recent experiment suggests.

healthNews reuters.com

Hospital patients are safe with substitute doctors

(Reuters Health) - Hospital patients’ survival rates don’t suffer when fill-in doctors substitute for the regular staff physicians, a U.S. study suggests.

healthNews reuters.com

Women get mixed messages about sexuality after childbirth

(Reuters Health) - Women receive mixed messages about the ways giving birth may affect their sex lives, according to a new report.

healthNews reuters.com

FDA approves Novo Nordisk diabetes drug Ozempic

(Reuters) - The U.S. Food and Drug Administration on Tuesday approved Novo Nordisk A/S's diabetes drug Ozempic, setting the stage for a heated competitive battle with Eli Lilly & Co's Trulicity.

healthNews reuters.com

Galectin slumps after NASH drug misses main goal of mid-stage trial

(Reuters) - Galectin Therapeutics Inc said its drug for the complex progressive fatty liver disease NASH led to some clinically meaningful results in patients with cirrhosis, but failed to achieve the main goal of a mid-stage trial, sending its shares plunging 48 percent on Tuesday.

healthNews reuters.com

Shire in deal to develop a new way to administer hemophilia drug

(Reuters) - Shire Plc said on Tuesday it had partnered with a California-based company to develop a new way to administer a drug to treat hemophilia A.

healthNews reuters.com

Galectin says NASH drug misses main goal of midstage trial

(Reuters) - Galectin Therapeutics Inc said on Tuesday its experimental drug for the complex progressive fatty liver disease NASH led to some clinically meaningful results in patients with cirrhosis, but failed to achieve the main goal of a midstage trial.

healthNews reuters.com

Philippines halts sale of dengue vaccine as Sanofi downplays risk

MANILA/LONDON (Reuters) - The Philippines has ordered French drugmaker Sanofi to stop the sale, distribution and marketing of its Dengvaxia dengue vaccine in the country after the company last week warned it could worsen the disease in some cases.

healthNews reuters.com

WHO backs Philippines suspension of Sanofi's dengue vaccine

GENEVA (Reuters) - The World Health Organization supported a decision by the Philippines Department of Health on Tuesday to suspend vaccinations with Sanofi's dengue drug Dengvaxia, the WHO said in a statement.

businessNews reuters.com

China's budding coffee culture propels Starbucks, attracts rivals

SHANGHAI/LOS ANGELES (Reuters) - In Wu Qiong's small cafe in downtown Shanghai, coffee beans nestle in glass jars on the bar while various brews bubble away behind the counter.

companyNews reuters.com

UPDATE 1-Amazon Australia goes live in time to ruin rivals' Christmas

* 23 categories including sports, shoes, clothes, electronics

healthNews reuters.com

Court-mandated opioid rehab rarely meets medical standards

(Reuters Health) - Fewer than one in 20 people with opioid addiction problems who are ordered into rehab programs by the courts receive methadone or buprenorphine, two drugs doctors consider the best treatment option, a U.S. study suggests.

healthNews reuters.com

Montana sues OxyContin maker Purdue over opioid epidemic

(Reuters) - Montana has sued OxyContin maker Purdue Pharma LP, withdrawing from a multistate investigation by attorneys general into opioid manufacturers' marketing practices and joining a growing list of states that have broken off to pursue individual lawsuits.

healthNews reuters.com

Trouble mounts for Sanofi dengue vaccine over safety concerns

(Reuters) - The World Health Organization said on Monday it hopes to review safety data on Sanofi's dengue vaccine this month, while the Philippines ordered an investigation of its now suspended massive immunization program after the French drugmaker said it could actually worsen the disease in some cases.

healthNews reuters.com

Tattooed wish for withholding treatment not good enough, doctors say

(Reuters Health) - Consumers are often told, "Put it in writing." But in the case of a hospitalized Florida man facing death, displaying his wish by having it tattooed on his chest wasn't good enough.

businessNews reuters.com

Amazon Australia goes live in time to ruin rivals' Christmas

SYDNEY (Reuters) - Amazon.com Inc's Australian arm said it would start taking orders on Tuesday, ending speculation about the timing of its launch in the world's No. 12 economy and likely dashing hopes of a holiday boost for struggling brick-and-mortar rivals.

companyNews reuters.com

UPDATE 4-Chipmaker Dialog plunges further on fears Apple could go it alone

* Shares fall 23 pct; down about 50 pct since in April (Adds Breakingviews link)

healthNews reuters.com

Healthcare prices hard to find online

Reuters Health - Consumers who search online for prices of common medical procedures may be disappointed by what they find, a U.S. study suggests.

healthNews reuters.com

Sanofi says monitoring outcomes of ongoing dengue vaccination schemes

PARIS (Reuters) - Sanofi on Monday said it was monitoring outcomes of ongoing public programs involving its dengue vaccine, Dengvaxia, following the launch of a probe in the Philippines.

Diabetes nytimes.com

Take a Number: Two Hidden Cancer Causes: Diabetes and Obesity

The conditions played a role in nearly 800,000 cases of cancer worldwide in 2012, researchers reported.

technologyNews reuters.com

Chipmaker Dialog plunges further on fears Apple could go it alone

LONDON/FRANKFURT (Reuters) - Shares in Dialog Semiconductor dropped as much as 23 percent on Monday after the company acknowledged for the first time that top customer Apple could develop its own battery-saving chips used in iPhones.

healthNews reuters.com

WHO reviewing data on Sanofi dengue vaccine, urges limited use

GENEVA (Reuters) - The World Health Organization (WHO) said on Monday it hoped to conduct a "full review" by year-end of data on Sanofi's dengue vaccine Dengvaxia.

companyNews reuters.com

UPDATE 3-Chipmaker Dialog plunges further on fears Apple could go it alone

* Shares fall 23 pct; down about 50 pct since in April (Adds further share price decline; analyst comments)

healthNews reuters.com

Poor regulation, dodgy pills spur plan for African drugs agency

LONDON (Reuters) - Last July, Ugandan officials seized fake versions of the cancer drug Avastin on sale in Kampala, revealing only the tip of an iceberg of bogus medicines found all too often in Africa.

healthNews reuters.com

Brazil recommends restrictions on Sanofi dengue vaccine

BRASILIA (Reuters) - The Brazilian government said on Monday it has suggested restrictions on the use of a dengue vaccine that has been suspended elsewhere after French drug company Sanofi SA said it could worsen the disease in some cases.

companyNews reuters.com

CEE MARKETS-Budapest bucks European stocks rally on Richter plunge

* Richter falls as EMA starts review of its Esmya drug * PKN Orlen rebound reverses Warsaw stock index decline * Zloty firms, Polish rate-setters may voice worry over CPI * Romanian 10-year bond sale draws solid demand after yield rise (Adds Romanian government bond auction, rebound of Warsaw stocks) By Sandor Peto and Radu-Sorin Marinas BUDAPEST/Bucharest, Dec 4 (Reuters) - Budapest stocks eased on Monday, dragged down by a sell-off in drugmaker Richter , now under inv

healthNews reuters.com

Therapix expects to have results of Tourette's drug trial by end of first quarter

TEL AVIV (Reuters) - Israel's Therapix Biosciences said on Monday it expects by the end of March to have the results from its mid-stage trial of a cannabinoid-based drug for treating Tourette's syndrome which could be worth billions of dollars in revenues.

companyNews reuters.com

BRIEF-Loxo Oncology Announces Updated Larotrectinib Pediatric Clinical Trial Data Demonstrating Continued Durability Of Response In TRK Fusion Cancers

* LOXO ONCOLOGY ANNOUNCES UPDATED LAROTRECTINIB PEDIATRIC CLINICAL TRIAL DATA DEMONSTRATING CONTINUED DURABILITY OF RESPONSE IN TRK FUSION CANCERS

healthNews reuters.com

Hungary's Richter says no link seen between Esmya drug and liver damage

BUDAPEST (Reuters) - Hungarian drugmaker Richter's clinical data for its uterine fibroid treatment Esmya indicate no demonstrable link with liver damage, the firm said on Monday.

healthNews reuters.com

Denmark's Alk Abello suspends dividend to support North America investment

(Reuters) - Danish pharma company Alk Abello said on Monday it would invest 1 billion Danish crowns ($159 million) in its North America business, a move that is expected put a lid on earnings and revenue growth in the near term.

healthNews reuters.com

Danish pharma company Alk Abello to invest 1 billion crowns in North America

(Reuters) - Danish pharma company Alk Abello said on Monday it would invest about 1 billion Danish crowns ($159.5 million) over the next three years to develop its North America business and said it expected earnings to be subdued during this period.

companyNews reuters.com

Roche's Foundation Medicine wins FDA blessing for new cancer test

ZURICH, Dec 4 (Reuters) - Roche on Monday said its Foundation Medicine unit won U.S. Food and Drug Administration (FDA) approval for a test to help doctors understand the genetic profile of patients' tumours and guide them to effective therapies.

healthNews reuters.com

Sanofi says no reported deaths in Philippines related to dengue vaccine

MANILA (Reuters) - There have been no reported deaths in the Philippines related to a suspended dengue vaccine made by Sanofi, an official from the pharmaceutical company said on Monday.

healthNews reuters.com

Cholera could resurge in Yemen due to lack of aid, fuel: WHO

GENEVA (Reuters) - Another wave of cholera could strike Yemen, where a Saudi-led coalition blockade has cut off fuel for hospitals, water pumps and vital aid supplies for starving children, the World Health Organization (WHO) said on Sunday.

healthNews reuters.com

Philippine president vows to get to the bottom of dengue vaccine 'health scam'

MANILA (Reuters) - The office of the Philippine president on Sunday vowed to hold accountable those responsible for a suspended dengue immunization program, which it said placed thousands of lives at risk.

healthNews reuters.com

U.S. Senate tax bill accomplishes major Obamacare repeal goal

WASHINGTON (Reuters) - The sweeping tax overhaul that passed the U.S. Senate on Saturday contains the Republicans' biggest blow yet to former President Barack Obama's healthcare law, repealing the requirement that all Americans obtain health insurance.

healthNews reuters.com

First U.S. birth for woman with transplanted uterus occurs in Texas

(Reuters) - For the first time in the United States, a woman with a transplanted uterus gave birth, officials at a Dallas hospital said on Friday.

healthNews reuters.com

Patients have different hospital outcomes when regular doctors see them

(Reuters Health) - Many outcomes for hospital patients – including how long they stay and their survival odds after they go home – may depend on whether they’re cared for by their primary care physician or another type of doctor, a U.S. study suggests.

healthNews reuters.com

FDA approves heart protection claims for Amgen cholesterol drug

(Reuters) - Amgen Inc can now promote the ability of its potent but expensive cholesterol drug to reduce the risk of heart attacks and strokes, after U.S. health regulators approved adding those benefits to the medicine's prescribing label, the company said on Friday.

healthNews reuters.com

Sanofi ends development of Clostridium difficile vaccine

(Reuters) - Pharmaceutical company Sanofi SA said on Friday that it had ended development of an experimental vaccine for Clostridium difficile infection, after an early look at late-stage trial results indicated a low probability for success.

healthNews reuters.com

Fetuses grow differently in obese women

(Reuters Health) - Obese pregnant women who don’t have serious medical problems are still more likely to have unusually large babies than mothers who aren’t obese, a recent study suggests.

healthNews reuters.com

Nestle, Stada prepare rival bids for Germany's Merck consumer health: sources

LONDON/FRANKFURT (Reuters) - Swiss food giant Nestle and the private equity owners of German drug firm Stada are both preparing tentative bids for Merck KgaA's consumer health unit, several sources told Reuters.

healthNews reuters.com

Cuba battling medicine shortages in wake of cash crunch

HAVANA (Reuters) - Cuba is working on fixing chronic medicine shortages that started appearing a year ago due to its cash crunch, health officials said in an article published late on Thursday in ruling Communist Party newspaper Granma.

companyNews reuters.com

REFILE-BRIEF-FDA Says Approves Mylan GmbH's Ogivri As First Biosimilar For Treatment Of Certain Breast, Stomach Cancers

* FDA SAYS APPROVES MYLAN GMBH'S OGIVRI AS A FIRST BIOSIMILAR FOR TREATMENT OF CERTAIN BREAST AND STOMACH CANCERS

healthNews reuters.com

FDA OKs Mylan's biosimilar of Roche cancer drug Herceptin

(Reuters) - The U.S. Food and Drug Administration on Friday approved Mylan NV's biosimilar of Herceptin, Roche's blockbuster treatment for breast cancer, making it the second copycat drug for cancer approved in the United States.

healthNews reuters.com

Smoking, drinking worsen prognosis for head and neck cancers

(Reuters Health) - People with head and neck cancers who smoke and drink are much more likely to die with these tumors than nonsmokers and teetotalers, a recent study suggests.

healthNews reuters.com

Doctors rarely discuss end-of-life care for chronic lung conditions

(Reuters Health) - Though most people suffering from chronic respiratory diseases want to discuss their preferences for end-of-life care with medical providers, they seldom do, a new review of past research suggests.

healthNews reuters.com

FDA approves Mylan's biosimilar of Roche's cancer drug Herceptin

(Reuters) - The U.S. Food and Drug Administration on Friday approved Mylan NV's biosimilar version of Roche's blockbuster breast cancer treatment Herceptin.

healthNews reuters.com

Italy needs to do more against olive tree disease: EU health chief

PARIS (Reuters) - The EU's top health official called on Italy to do more to contain a bacterium that has ravaged olive groves in part of the country and for which no treatment currently exists.

companyNews reuters.com

BRIEF-FDA Says Approves Mylan GmbH's Ogivri As First Biosimilar For Treatment Of Certain Breast, Stomach Cancers

* FDA SAYS APPROVES MYLAN GMBH'S OGIVRI AS A FIRST BIOSIMILAR FOR TREATMENT OF CERTAIN BREAST AND STOMACH CANCERS

healthNews reuters.com

Indivior drug to fight opioid addiction approved by U.S. FDA

(Reuters) - Indivior's experimental drug to help fight America's growing opioid addiction crisis was approved by the U.S. Food and Drug Administration late on Thursday, boosting its sales prospects as competitors threaten revenues from an older product.

companyNews reuters.com

Beauty contest: China make-up brands rein in South Korea rivals

SEOUL/SHANGHAI, Dec 1(Reuters) - As a diplomatic spat between Beijing and Seoul raged this year, many South Koreans felt decidedly unwelcome in China. South Korean businesses were shunned, K-pop concerts were canceled and tourist trade dried up.

healthNews reuters.com

Genmab and Johnson & Johnson 'love' partnership as some ponder takeover

LONDON (Reuters) - Genmab was Europe's second biggest biotech company, until its partner Johnson & Johnson bought Switzerland's Actelion for $30 billion this year and propelled the Danish antibody specialist to the top spot.

healthNews reuters.com

Cancer drug prompts 'drastic' HIV decrease in lung cancer patient

LONDON, (Reuters) - Doctors in France have found the first evidence that a drug normally used to treat lung, kidney or skin cancer may be able to eradicate HIV-infected cells in people with the AIDS virus.

healthNews reuters.com

Foundation's cancer gene test gets U.S. FDA and Medicare nod

CHICAGO (Reuters) - A test from Foundation Medicine Inc that can detect cancer-causing mutations in 324 genes has won approval from the U.S. Food and Drug Administration and the Center for Medicare and Medicaid Services, the agencies said.

companyNews reuters.com

UPDATE 1-Foundation's cancer gene test gets U.S. FDA and Medicare nod

CHICAGO, Nov 30 (Reuters) - A test from Foundation Medicine Inc that can detect cancer-causing mutations in 324 genes has won approval from the U.S. Food and Drug Administration and the Center for Medicare and Medicaid Services, the agencies said.

healthNews reuters.com

Marriage linked to lower dementia risk

(Reuters Health) - Being married, or ever having been married, comes with a much lower risk of developing dementia compared to being a lifelong bachelor or bachelorette, a new analysis of previous studies suggests.

healthNews reuters.com

Foundation Medicine gets nod from FDA and Medicare for cancer test

CHICAGO (Reuters) - A test from Foundation Medicine Inc that can detect cancer-causing mutations in 324 genes has won simultaneous approval from the U.S. Food and Drug Administration and the Center for Medicare and Medicaid Services, the agencies said in a statement on Thursday.

healthNews reuters.com

Exclusive: U.S. health regulator Verma eyes new methods for drug pricing

NEW YORK (Reuters) - The U.S. government is considering setting new payment methods aimed at curbing costs for Medicare and Medicaid coverage of breakthrough medical treatments with very high prices, particularly novel gene-based therapies for cancer and other diseases, a top health official said on Thursday.

healthNews reuters.com

Some hospital services may be expendable on weekends

(Reuters Health) - Removing allied healthcare services from hospitals on weekends may not affect patient outcomes, suggests a new Australian study.

healthNews reuters.com

Lawsuit seeks to block Illinois abortion coverage expansion

CHICAGO (Reuters) - Abortion opponents in Illinois filed a lawsuit on Thursday to block a recently approved law expanding state-funded coverage of abortions for low-income Medicaid recipients and state workers.

healthNews reuters.com

‘Overlapping’ neurosurgery not tied to higher complication or death rates

(Reuters Health) – Most neurosurgery patients are no more likely to die or suffer serious complications when their surgeon is involved in more than one operation at the same time, a recent U.S. study suggests.

healthNews reuters.com

Hospital quality-control program tied to rise in heart failure deaths

(Reuters Health) - Financial penalties designed to encourage hospitals to avoid repeat hospitalizations are working, but they’re also associated with higher mortality rates for patients with heart failure, a U.S. study suggests.

healthNews reuters.com

France stops large shipment of radioactive Belarus mushrooms

PARIS (Reuters) - France has stopped a large shipment of Belarus mushrooms contaminated with low-level radioactivity probably from Chernobyl and not linked to a radioactive cloud that appeared in southern Russia last month, officials said on Thursday.

healthNews reuters.com

Farmers harder hit by opioid crisis than rest of rural U.S.: survey

CHICAGO (Reuters) - The opioid crisis in the United States is impacting farm and ranch families more acutely than their rural neighbors, according to a survey published by the American Farm Bureau Federation (AFBF) and the National Farmers Union on Thursday.

healthNews reuters.com

UK doctors test less invasive prenatal screening for Down syndrome

(Reuters Health) - Pregnant women may get accurate screening results for Down syndrome – also known as trisomy 21 - and two rarer chromosomal disorders with a finger-prick blood test that reduces the need for more invasive diagnostic procedures, a UK study suggests.

healthNews reuters.com

FDA aims to approve more drugs based on early clinical data

(Reuters) - The U.S. Food and Drug Administration is aiming to approve drugs based on very early data if the drug shows a possible benefit in terms of survival, the head of the agency told lawmakers at a hearing on Thursday.

companyNews reuters.com

Total starts up Antwerp refinery and petrochem complex after upgrade

PARIS, Nov 30 (Reuters) - French oil and gas company Total said on Thursday that production had resumed gradually at its 338,000 barrels-per-day refinery and petrochemical platform in Antwerp, Belgium after a $1 billion upgrade.

healthNews reuters.com

France stops large shipment of radioactive Belarusian mushrooms

PARIS (Reuters) - France has stopped a large shipment of Belarus mushrooms contaminated with radioactivity from Chernobyl but there is no link with a radioactive cloud from Russia last month.

healthNews reuters.com

France finds traces of radioactive cesium in Russian mushrooms

PARIS (Reuters) - France has found traces of radioactive cesium on mushrooms imported from Russia, the head of French nuclear regulator ASN said on Thursday.

healthNews reuters.com

Genmab and J&J 'love' partnership as some ponder takeover

LONDON (Reuters) - Genmab was Europe's second biggest biotech company, until its partner Johnson & Johnson bought Switzerland's Actelion for $30 billion this year and propelled the Danish antibody specialist to the top spot.

healthNews reuters.com

Vaccine alliance backs typhoid shots for poor with $85 million

LONDON (Reuters) - The GAVI global vaccine alliance has earmarked $85 million to help support the introduction of typhoid vaccines in poor countries where millions of children are at risk of the often deadly disease.

healthNews reuters.com

Europe's top biotech expects delays from drugs watchdog's HQ move

LONDON (Reuters) - Europe's biggest biotechnology company, Denmark's Genmab, expects some delays to regional drug approvals as the European Medicines Agency is uprooted from London to Amsterdam.

healthNews reuters.com

France finds traces of radioactive cesium in Russian mushrooms: ASN

PARIS (Reuters) - France has found traces of radioactive cesium on mushrooms imported from Russia, the head of French nuclear regulator ASN said on Thursday.

worldNews reuters.com

Migration to UK plunges in year after Brexit, driven by EU citizens

LONDON (Reuters) - Net migration to Britain fell sharply by 106,000 to 230,000 people in the 12 months to June, with more than three-quarters of the drop due to EU citizens, official data showed on Thursday.

healthNews reuters.com

New vaccine, long-acting drug trials buoy hopes in HIV fight

LONDON (Reuters) - Researchers announced the launch of two big studies in Africa on Thursday to test a new HIV vaccine and a long-acting injectable drug, fuelling hopes for better ways to protect against the virus that causes AIDS.

companyNews reuters.com

RPT-UPDATE 2-Unilever touts new products, structure to fight rivals

LONDON, Nov 29 (Reuters) - Anglo-Dutch consumer goods maker Unilever told investors on Wednesday that it expects new products and a leaner organization to help win an intensifying battle to sell packaged goods around the world.

worldNews reuters.com

Honduran election crisis festers as rivals claim victory

TEGUCIGALPA (Reuters) - Four days after voting in a presidential election, Honduras sank deeper into crisis on Thursday, with no clear winner in sight and the vote count disputed by the U.S.-friendly incumbent's centrist rival, a television game show host allied with leftists.

worldNews reuters.com

Election crisis engulfs Honduras with rivals neck-and-neck

TEGUCIGALPA (Reuters) - Honduras faced a growing election crisis on Wednesday, with its U.S.-friendly president edging ahead in troubled vote count that his centrist rival, a television game show host allied with leftists, has rejected, saying he is being robbed.

businessNews reuters.com

Tech share plunge drags Asian stocks lower

TOKYO (Reuters) - Asian shares fell on Thursday, weighed down by a plunge in high-flying technology shares, a move that some see as a healthy correction after a strong rally but others believe may herald the peak of a "super cycle" that has been boosting the sector.

companyNews reuters.com

GLOBAL MARKETS-Tech share plunge drags Asian stocks lower

TOKYO, Nov 30 (Reuters) - Asian shares fell on Thursday, weighed down by a plunge in high-flying technology shares, a move that some see as a healthy correction after a strong rally but others believe may herald the peak of a "super cycle" that has been boosting the sector.

worldNews reuters.com

Palestinian rivals delay full Gaza handover by 10 days

GAZA (Reuters) - Rival Palestinian factions Fatah and Hamas agreed on Wednesday to delay final transfer of power of the Gaza Strip from Hamas to the Western-backed Palestinian government by 10 days to Dec. 10 to allow time to "complete arrangements", officials said.

healthNews reuters.com

Forecast predicts over half of U.S. children will be obese by age 35

(Reuters Health) - Nearly three in five children in the U.S. today are destined to be obese when they reach their 35th birthday, according to a new projection.

healthNews reuters.com

Smartphone pics may be sharp enough for dermatology diagnosis

(Reuters Health) - With a few exceptions, a dermatologist was just as accurate in diagnosing children’s skin conditions from smartphone photos taken by parents as the doctors who saw the kids in person, a small U.S. study found.

healthNews reuters.com

Epidurals with fentanyl not linked to lower odds of breastfeeding

(Reuters Health) - Women who get epidural pain relief that includes the opioid fentanyl are no less likely to breastfeed their babies than mothers who get epidurals without this drug, a small study suggests.

healthNews reuters.com

FDA moves to speed nicotine replacement product development

(Reuters) - The U.S. Food and Drug Administration said on Wednesday it is considering measures to speed development of products that help people quit smoking, including easing requirements for approval of over-the-counter nicotine replacement therapies.

healthNews reuters.com

Bodybuilding products sold online may be mislabeled or unsafe

(Reuters Health) - Many bodybuilding products sold online are mislabeled and contain unapproved drugs and other ingredients that may not be safe, a new study suggests.

healthNews reuters.com

Sanofi expects $120 million hit as dengue vaccine hits major snag

PARIS (Reuters) - Use of Sanofi's dengue vaccine, the world's first approved shot against the mosquito-borne virus, is to be strictly limited due to evidence it can worsen the disease in people who have not previously been exposed to the infection. The French drugmaker said in a statement on Wednesday that as a result it would book a charge in its fourth-quarter results of around 100 million euros ($118.57 million).

healthNews reuters.com

Insecticide resistance spreads in Africa, threatens malaria progress

LONDON (Reuters) - The largest genetic study of mosquitoes has found their ability to resist insecticides is evolving rapidly and spreading across Africa, putting millions of people at higher risk of contracting malaria.

healthNews reuters.com

Health secretary nominee Azar says lowering drug prices a top priority

WASHINGTON (Reuters) - Alex Azar, a former drug industry executive and lobbyist nominated to run the U.S. Department of Health and Human Services, promised on Wednesday to lower drug prices and said he was unaware of any efforts to sabotage the healthcare law passed under former President Barack Obama.

healthNews reuters.com

U.S. to open office, award grants in opioid fight

WASHINGTON (Reuters) - The U.S. Justice Department said Wednesday it was launching a Drug Enforcement Administration field office in the Appalachian region at the center of the opioid crisis and would issue $12 million in grant funding to help assist law enforcement.

healthNews reuters.com

Health secretary nominee Azar says drug pricing a top priority

WASHINGTON (Reuters) - Alex Azar, a former drug industry executive who Republicans have nominated to run the U.S. Department of Health and Human Services, on Wednesday promised to lower drug prices that he said are too high, saying he would look at abuse of patent laws that delays generic competition.

healthNews reuters.com

WHO fears complacency as progress against malaria stalls

LONDON, Nov 29 (Reuters) - Progress in the global fight against malaria has stalled amid signs of flatlining funding and complacency that the mosquito-borne disease is less of a threat, the World Health Organization said on Wednesday.

healthNews reuters.com

The doctor will see you now - but often not for long

(Reuters Health) - For half of the world’s population, primary care doctor visits last less than five minutes, researchers say.

healthNews reuters.com

Hip fracture surgery delays tied to higher odds of death

(Reuters Health) - Many patients with fractured hips don’t get surgery quickly enough to avoid an increased risk of complications and death, a Canadian study suggests.

healthNews reuters.com

One in three U.S. adults with hearing problems don’t seek help

(Reuters Health) - Almost one-third of an estimated 40 million U.S. adults with hearing difficulties haven’t seen a specialist for help, a new study suggests.

healthNews reuters.com

U.S. HIV diagnoses improving, but progress varies: CDC

CHICAGO (Reuters) - Delays in the time between becoming infected with HIV and getting a diagnosis are shortening, helped by efforts to increase testing for the virus that causes AIDS, U.S. health officials said.

healthNews reuters.com

Fathers’ depression affects kids’ depression, too

(Reuters Health) - Fathers who show signs of depression may be more likely to have kids who show signs of depression, especially in their teen years, according to a new study in the United Kingdom and Ireland.

healthNews reuters.com

WHO fears deadly diphtheria outbreak among Rohingya refugees

GENEVA (Reuters) - Hundreds of thousands of Rohingya refugees who fled from Myanmar into Bangladesh are at risk from a possible outbreak of diphtheria, the World Health Organization said in a report published on Tuesday.

companyNews reuters.com

UPDATE 2-Auris Medical shares plunge as deafness drug trial scrapped

* Shares plummet >50 pct to $0.38 (Adds background, details on Auris' pipeline; updates shares)

companyNews reuters.com

UPDATE 2-Merck KGaA, Pfizer's immunotherapy fails in gastric cancer trial

* Results from use against lung cancer still outstanding (Adds share price, analyst's comment)

healthNews reuters.com

Tens of thousands dying from $30 billion fake drugs trade, WHO says

LONDON (Reuters) - One in 10 drugs sold in developing countries is fake or substandard, leading to tens of thousands of deaths, many of them of African children given ineffective treatments for pneumonia and malaria, health officials said on Tuesday.

healthNews reuters.com

Merck KGaA, Pfizer's immunotherapy fails in gastric cancer trial

FRANKFURT (Reuters) - Germany's Merck KGaA suffered a setback in the development of key cancer immunotherapy Bavencio, which failed to prolong lives in gastric cancer patients when compared with standard chemotherapy.

companyNews reuters.com

UPDATE 1-Merck KGaA, Pfizer's immunotherapy fails in gastric cancer trial

* Results from use against lung cancer still outstanding (Adds rival drugs, Pfizer executive comment, background on class)

healthNews reuters.com

German minister's vote on weed-killer should not happen again: Merkel

BERLIN (Reuters) - German Chancellor Angela Merkel on Tuesday said she regretted a conservative minister's vote in favor of an EU proposal to extend the use of a weed-killer against the wishes of a cabinet colleague, adding such incident should not happen again.

healthNews reuters.com

Merck KGaA, Pfizer's avelumab misses goal in gastric cancer trial

FRANKFURT (Reuters) - Germany's Merck KGaA said on Tuesday that its cancer immunotherapy avelumab, jointly developed with Pfizer, failed to improve overall survival compared with standard chemotherapy in a late-stage study on gastric cancer patients.

healthNews reuters.com

Takeda moves ahead in Zika race with launch of vaccine trial

LONDON (Reuters) - Japan's Takeda Pharmaceutical has moved ahead in the race to develop a vaccine for the mosquito-borne Zika virus, with the start of a clinical trial program backed by the U.S. government.

healthNews reuters.com

Europe's HIV epidemic growing at alarming rate, WHO warns

LONDON (Reuters) - The number of people newly diagnosed with HIV in Europe reached its highest level in 2016 since records began, showing the region's epidemic growing "at an alarming pace", health officials said on Tuesday.

healthNews reuters.com

Text-message ‘blast’ can expand access to surgical services

(Reuters Health) - Dozens of patients in Zimbabwe undergoing cleft lip and palate surgery had first learned about the opportunity from an SMS text to their phones, a small study found.

companyNews reuters.com

BRIEF-‍Grace Licenses Unipol PP Process Technology To Sinochem Quanzhou Petrochemical In China​

* ‍GRACE LICENSES UNIPOL® PP PROCESS TECHNOLOGY TO SINOCHEM QUANZHOU PETROCHEMICAL CO., LTD. IN CHINA​

healthNews reuters.com

Patient satisfaction plummets when doctors say ‘no’ to requests

(Reuters Health) - Patients may become less satisfied with their care when doctors refuse their requests for things like prescriptions or lab tests, a U.S. study suggests.